Primary |
Schizophrenia, Paranoid Type |
100.0% |
|
|
Secondary |
Product Used For Unknown Indication |
40.9% |
Drug Use For Unknown Indication |
13.2% |
Schizophrenia |
10.0% |
Schizophrenia, Paranoid Type |
9.6% |
Psychotic Disorder |
7.1% |
Insomnia |
2.6% |
Schizoaffective Disorder |
2.6% |
Mania |
2.5% |
Agitation |
1.5% |
Depression |
1.1% |
Dysthymic Disorder |
1.1% |
Hiv Infection |
1.1% |
Ill-defined Disorder |
1.1% |
Epilepsy |
1.0% |
Renal Failure Chronic |
1.0% |
Childhood Psychosis |
0.8% |
Digeorge's Syndrome |
0.8% |
Cyclothymic Disorder |
0.7% |
Extrapyramidal Disorder |
0.7% |
Hypothyroidism |
0.7% |
|
Schizophrenia |
17.0% |
Neutropenia |
6.8% |
Vomiting |
6.8% |
Leukopenia |
5.7% |
Overdose |
5.7% |
Sopor |
5.7% |
Tachypnoea |
5.7% |
Cerebellar Syndrome |
4.5% |
Sudden Death |
4.5% |
Weight Increased |
4.5% |
Gastrointestinal Necrosis |
3.4% |
Hypoglycaemia |
3.4% |
Myositis |
3.4% |
Renal Failure Chronic |
3.4% |
Rhabdomyolysis |
3.4% |
Sinus Tachycardia |
3.4% |
Underdose |
3.4% |
Urinary Incontinence |
3.4% |
Withdrawal Syndrome |
3.4% |
Abnormal Behaviour |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
22.9% |
Drug Use For Unknown Indication |
18.4% |
Schizophrenia |
11.4% |
Psychotic Disorder |
6.8% |
Bipolar Disorder |
5.7% |
Schizoaffective Disorder |
5.0% |
Depression |
4.5% |
Thinking Abnormal |
2.9% |
Bipolar I Disorder |
2.3% |
Psychiatric Symptom |
2.3% |
Anxiety |
2.1% |
Abnormal Behaviour |
2.0% |
Epilepsy |
2.0% |
Agitation |
1.8% |
Deep Vein Thrombosis |
1.8% |
Extrapyramidal Disorder |
1.8% |
Hiv Infection |
1.6% |
Mania |
1.6% |
Mood Altered |
1.6% |
Mood Swings |
1.4% |
|
Weight Increased |
18.8% |
Vomiting |
9.9% |
Overdose |
7.9% |
Nervous System Disorder |
6.9% |
Somnolence |
5.9% |
Death |
5.0% |
Psychotic Disorder |
5.0% |
Sinus Bradycardia |
5.0% |
Neutropenia |
4.0% |
Suicide Attempt |
4.0% |
Tachycardia |
4.0% |
Tremor |
4.0% |
Feeling Abnormal |
3.0% |
Hypoglycaemia |
3.0% |
Mental Impairment |
3.0% |
Sudden Death |
3.0% |
Balance Disorder |
2.0% |
Blister |
2.0% |
Blood Cholesterol Increased |
2.0% |
Hepatic Enzyme Increased |
2.0% |
|
Interacting |
Drug Use For Unknown Indication |
21.0% |
Psychotic Disorder |
13.6% |
Abdominal Pain |
12.3% |
Personality Disorder |
12.3% |
Agitation |
11.1% |
Abnormal Behaviour |
7.4% |
Insomnia |
6.2% |
Pain |
6.2% |
Hiv Infection |
3.7% |
Mania |
3.7% |
Epilepsy |
1.2% |
Product Used For Unknown Indication |
1.2% |
|
Urinary Incontinence |
25.0% |
Drug Interaction |
12.5% |
Muscle Rigidity |
12.5% |
Urinary Retention |
12.5% |
Accidental Overdose |
6.3% |
Convulsion |
6.3% |
Dyskinesia |
6.3% |
Respiratory Depression |
6.3% |
Status Epilepticus |
6.3% |
Thrombophlebitis Septic |
6.3% |
|